Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients—The European MelSkinTox study
L'Orphelin, J.‐M., Cassecuel, J., Kandolf, L., Harwood, C. A., Tookey, P., Junejo, M. H., Hogan, S., Lebbé, C., Appalla, Z., Kränke, T.‐M., Pellacani, G., Cerasuolo, D., Dujovic, B., Del Marmol, V., Forschner, A., Garbe, C., Bataille, V., Ressler, J. M., Sollena, P., Dompmartin, A., Peris, K., Dreno, B.
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2023)
Published in Journal of the European Academy of Dermatology and Venereology (01.08.2023)
Get full text
Journal Article